<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR814.html">Part 814
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 814.9  Confidentiality of data and information in a premarket
                            </h3>
                            <p class="depth1"><em>(a)</em> A ``PMA file'' includes all data and information submitted with  or incorporated by reference in the PMA, any IDE incorporated into the  PMA, any PMA supplement, any report under Sec. 814.82, any master file,  or any other related submission. Any record in the PMA file will be  available for public disclosure in accordance with the provisions of  this section and part 20. The confidentiality of information in a color  additive petition submitted as part of a PMA is governed by Sec. 71.15.</p><p class="depth1"><em>(b)</em> The existence of a PMA file may not be disclosed by FDA before  an approval order is issued to the applicant unless it previously has  been publicly disclosed or acknowledged.</p><p class="depth1"><em>(c)</em> If the existence of a PMA file has not been publicly disclosed  or acknowledged, data or information in the PMA file are not available  for public disclosure.</p><p class="depth1"><em>(d)</em></p><p class="depth2"><em>(1)</em> If the existence of a PMA file has been publicly disclosed or  acknowledged before an order approving, or an order denying approval of  the PMA is issued, data or information contained in the file are not  available for public disclosure before such order issues. FDA may,  however, disclose a summary of portions of the safety and effectiveness  data before an approval order or an order denying approval of the PMA  issues if disclosure is relevant to public consideration of a specific  pending issue.</p><p class="depth2"><em>(2)</em> Notwithstanding paragraph (d)(1) of this section, FDA will make  available to the public upon request the information in the IDE that was  required to be filed in Docket Number 95S-0158 in the Division of  Dockets Management (HFA-305), Food and Drug Administration, 12420  Parklawn Dr., rm. 1-23, Rockville, MD 20857, for investigations  involving an exception from informed consent under Sec. 50.24 of this  chapter. Persons wishing to request this information shall submit a  request under the Freedom of Information Act.</p><p class="depth1"><em>(e)</em> Upon issuance of an order approving, or an order denying  approval of any PMA, FDA will make available to the public the fact of  the existence of the PMA and a detailed summary of information submitted  to FDA respecting the safety and effectiveness of the device that is the  subject of the PMA and that is the basis for the order.</p><p class="depth1"><em>(f)</em> After FDA issues an order approving, or an order denying  approval of any PMA, the following data and information in the PMA file  are immediately available for public disclosure:</p><p class="depth2"><em>(1)</em> All safety and effectiveness data and information previously  disclosed to the public, as such disclosure is defined in Sec. 20.81.</p><p class="depth2"><em>(2)</em> Any protocol for a test or study unless the protocol is shown to  constitute trade secret or confidential commercial or financial  information under Sec. 20.61.</p><p class="depth2"><em>(3)</em> Any adverse reaction report, product experience report, consumer  complaint, and other similar data and information, after deletion of:</p><p class="depth3"><em>(i)</em> Any information that constitutes trade secret or confidential  commercial or financial information under Sec. 20.61; and</p><p class="depth3"><em>(ii)</em> Any personnel, medical, and similar information disclosure of  which would constitute a clearly unwarranted invasion of personal  privacy under Sec. 20.63; provided, however, that except for the  information that constitutes trade secret or confidential commercial or  financial information under Sec. 20.61, FDA will disclose to a patient  who requests a report all the information in the report concerning that  patient.</p><p class="depth2"><em>(4)</em> A list of components previously disclosed to the public, as such  disclosure is defined in Sec. 20.81.</p><p class="depth2"><em>(5)</em> An assay method or other analytical method, unless it does not  serve any regulatory purpose and is shown to fall within the exemption  in Sec. 20.61 for trade secret or confidential commercial or financial  information.</p><p class="depth2"><em>(6)</em> All correspondence and written summaries of oral discussions  relating to the PMA file, in accordance with the provisions of  Sec. Sec. 20.103 and 20.104.</p><p class="depth1"><em>(g)</em> All safety and effectiveness data and other information not  previously disclosed to the public are available for public disclosure  if any one of the following events occurs and the data and information  do not constitute trade secret or confidential commercial or financial  information under Sec. 20.61:</p><p class="depth2"><em>(1)</em> The PMA has been abandoned. FDA will consider a PMA abandoned  if:</p><p class="depth3"><em>(i)</em></p><p class="depth4"><em>(A)</em> The applicant fails to respond to a request for additional  information within 180 days after the date FDA issues the request or</p><p class="depth4"><em>(B)</em> Other circumstances indicate that further work is not being  undertaken with respect to it, and</p><p class="depth3"><em>(ii)</em> The applicant fails to communicate with FDA within 7 days after  the date on which FDA notifies the applicant that the PMA appears to  have been abandoned.</p><p class="depth2"><em>(2)</em> An order denying approval of the PMA has issued, and all legal  appeals have been exhausted.</p><p class="depth2"><em>(3)</em> An order withdrawing approval of the PMA has issued, and all  legal appeals have been exhausted.</p><p class="depth2"><em>(4)</em> The device has been reclassified.</p><p class="depth2"><em>(5)</em> The device has been found to be substantially equivalent to a  class I or class II device.</p><p class="depth2"><em>(6)</em> The PMA is considered voluntarily withdrawn under Sec.  814.44(g).</p><p class="depth1"><em>(h)</em> The following data and information in a PMA file are not  available for public disclosure unless they have been previously  disclosed to the public, as such disclosure is defined in Sec. 20.81,  or they relate to a device for which a PMA has been abandoned and they  no longer represent a trade secret or confidential commercial or  financial information as defined in Sec. 20.61:</p><p class="depth2"><em>(1)</em> Manufacturing methods or processes, including quality control  procedures.</p><p class="depth2"><em>(2)</em> Production, sales, distribution, and similar data and  information, except that any compilation of such data and information  aggregated and prepared in a way that does not reveal data or  information which are not available for public disclosure under this  provision is available for public disclosure.</p><p class="depth2"><em>(3)</em> Quantitative or semiquantitative formulas.  [51 FR 26364, July 22, 1986, as amended at 61 FR 51531, Oct. 2, 1996]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
